Soloway Mark S, Lee Cheryl T, Steinberg Gary D, Ghandi Abdullah Al, Jewett Michael A S
Department of Urology, University of Miami/Jackson Memorial Hospital, Miami, FL 33101, USA.
Urol Oncol. 2007 Jul-Aug;25(4):338-40. doi: 10.1016/j.urolonc.2007.05.002.
Management decisions for a patient with high grade (G3) T1 urothelial cancer of the bladder are critical. These tumors should not be classified as "superficial" since they are not confined to the urothelium. Patients with T1G3 bladder cancers are likely to have recurrence and the tumor will often progress, invade, metastasize, and cause death. Radical cystectomy as well as transurethral resection followed by intravesical BCG are acceptable initial therapies. This article reviews these treatment options and provides recommendations for management of high grade T1 tumors.
对于患有高级别(G3)膀胱T1期尿路上皮癌的患者,管理决策至关重要。这些肿瘤不应被归类为“浅表性”,因为它们并不局限于尿路上皮。T1G3膀胱癌患者很可能会复发,而且肿瘤常常会进展、侵犯、转移并导致死亡。根治性膀胱切除术以及经尿道切除术加膀胱内卡介苗灌注是可接受的初始治疗方法。本文回顾了这些治疗选择,并为高级别T1肿瘤的管理提供建议。